Stanford Health Care’s menopause records connect an educational overview to specialist appointments and a treatment service. The treatment page expressly mentions video visits and in-person locations throughout the Bay Area. That gives readers a useful access distinction without establishing that every new patient or every concern can be handled remotely.
This review examines the two official pages checked September 28, 2026. It separates the provider’s stated clinical menu from the details a consultation would need to establish: the reason for care, the appointment format, an individual recommendation and the financial terms. No visit, prescription request or patient outcome was tested for this review.
Stanford documents menopause specialists and hormonal and nonhormonal care. Its video-visit statement is not proof of nationwide eligibility, a stocked estrogen product or a complete treatment price.
A specialist contact anchors the offering
Both the menopause overview and treatment page direct appointment requests to 650-725-6079. The treatment record describes menopause specialists and a multidisciplinary service. Together, these establish a care offering rather than a standalone health-education article.
The pages also contain general MyHealth portal information. Portal access supports tasks such as messaging, appointments and billing, but does not itself establish acceptance into the menopause service. When contacting Stanford, a reader can specify whether the request concerns a first evaluation, an existing treatment or another opinion. The reviewed record does not show the current waiting list or the clinician who would receive the request.
Video and Bay Area access need separate confirmation
Stanford’s treatment page advertises video visits and in-person locations throughout the Bay Area. It does not supply a nationwide eligibility guarantee in the reviewed text. A person considering video care still needs confirmation of the appointment type, clinician and location-related requirements that apply to the proposed visit.
The UCLA Health review emphasizes a named-program request and advance intake, while the Johns Hopkins review preserves an explicit referral requirement and conditional geography. These comparisons show why virtual access cannot be inferred from the size of a hospital system or the existence of a portal. Stanford’s record supports asking about video care, not promising it to every reader.
Assessment is not a self-selected hormone test
The overview explains that clinicians often identify perimenopause or menopause from the clinical history and symptoms, while blood tests may be considered in some circumstances. This is Stanford’s description of assessment, not an instruction for a reader to request, decline or interpret a particular test. The same page notes that some symptoms can resemble other conditions.
The questions-before-starting-estrogen guide helps frame what has changed and what needs explanation. A consultation can clarify whether an existing result is relevant and whether additional assessment is needed. Neither the public overview nor this review establishes a diagnosis from age, a symptom checklist or a single laboratory value.
The hormone list does not identify the prescribed product
The treatment page names delivery forms including patches, pills, gels, sprays, creams and vaginal rings. It also says personal and family medical history are considered when assessing hormone therapy. Those statements describe topics within the service; they do not identify the exact medicine, strength, availability or dispensing pharmacy for a future patient.
The patch-versus-pill guide and local-versus-systemic guide provide terminology for that conversation. A reader should not equate every listed form with the same treatment purpose. This review does not reproduce broad promotional benefit claims from the page as universal clinical conclusions, and it does not translate a provider’s treatment menu into a personal hormone regimen.
Nonhormonal services broaden the conversation
Stanford also describes nonhormonal medicines and products, pelvic-floor therapy, sleep assessment and other approaches. That makes it clear the service is not solely a route to estrogen. However, the presence of a treatment category does not show that it is part of every visit or that every named intervention is suitable for a particular person.
For a comparison with another broad midlife service, the University of Utah Health review follows a program with its own intake and referral context. The useful question for either institution is which concern a proposed service is meant to address, who provides it and how it connects with existing care. The number of categories listed is not a clinical quality score.
The overview includes a clear care-contact boundary
Stanford’s overview says to contact a doctor right away for heavy bleeding with clots, periods lasting longer than ten days or occurring every other week, and vaginal bleeding after menopause. These are the provider’s published care-contact warnings. They should not be turned into reassurance that other bleeding patterns are harmless or into a diagnosis made by this review.
An appointment-request number and a patient portal are administrative or established-care tools; the reviewed records do not establish their response times for a new clinical concern. A person using the service needs to know which channel the care team identifies for prompt clinical questions. This article supplies no automated assessment or personalized triage result.
Price and responsibility remain part of the decision
Neither reviewed Stanford page established a fixed menopause-consultation fee, a recurring membership price or a complete amount covering medicines and follow-up. The treatment list also does not define who would manage a prescription if another clinician remains involved. Those are material limits for someone comparing a health-system consultation with online care.
Stanford is supported as a provider by its specialist appointment route, stated access formats and clinical service description. A useful next inquiry concerns the selected appointment, expected charges and who handles results and subsequent questions. The review does not rank Stanford above another brand based on institutional reputation, specialist credentials or the availability of research opportunities mentioned on its website.
Sources & reading
Source check dates appear with each record below. Provider pages describe their own services; they do not establish clinical superiority.
- Stanford Health Care: Menopause overview and appointments ↗Primary health-system service record; published clinical scope and appointment limitations · Checked 2026-09-28
- Stanford Health Care: Menopause treatments and access ↗Primary health-system service record; published clinical scope and appointment limitations · Checked 2026-09-28